Results for "HDA Factbook"
Chip Davis Shares HDA’s 2025 Policy Priorities in Annual Chain Drug Review Column
In his annual “Health Care Outlook” column featured in Chain Drug Review, HDA’s President and CEO Chip Davis outlines a series of key policy priorities for healthcare distributors in 2025, as well as some challenges he expects the industry to face.
HDA Statement on Federal Trade Commission and Health and Human Services RFI on Drug Shortages
HDA commented on the release of an FTC and HHS Request for Information (RFI) investigating the causes of drug shortages.
HDA’s Emerging Leaders Program Helps Up-and-Coming Professionals Grow Their Careers
The pharmaceutical distribution sector is full of exciting opportunities for young professionals, whose fresh perspectives and innovative ideas will help enhance supply chain efficiency and security.
DSCSA 2023: Dispensers’ Role and Responsibilities
At HDA’s third Traceability Webinar on September 15, HDA’s Elizabeth Gallenagh, General Counsel and Senior Vice President, Supply Chain Integrity, spoke to Perry Fri, Executive Vice President, Industry Relations, Membership and Education, HDA; and Chief Operating Officer, HDA Research Foundation to dispel myths and offer clarity around the dispenser’s role and legal responsibilities per DSCSA requirements.